Replies to post #420846 on Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

About half what we do today.", 527M O/S Feb 2014. $0.40, $2.10 & $2.75 were 3 options with $2.10 being communicated the most likely. This was pre-opioid crisis when Nasrat expected SequestOx tech to be on path to approval. The plan was to use this tech and create a "treadmill" of drugs we could apply it to and drive continual growth in opioid space and capture market. 

[Just give me $1.50]

Amazing post. Great minds think alike.

hope company doesn't get bought for at least another year and a half to get sales ramped up on Vyvanse and believe waiting ultimately will get us a higher position, particularly if on NASDAQ vs. Otc.